Ambrobene 75 mg 20 capsules
- Medication package insert
- Ingredient
- Specifications
- Photos & Videos 1
- Alternatives 8
- Accessories and suggested products
Ambrobene 75 mg 20 capsules
The medicinal product Ambrobene 75 mg
One capsule contains ambroxol hydrochloridum 75 mg. 20 capsules
Ambrobene hard capsules with prolonged release are used in acute and chronic respiratory tract diseases associated with difficulty coughing, infectious diseases of the respiratory tract, in acute and chronic inflammation of the sinuses. It can be used without medical advice in acute respiratory conditions such as acute bronchitis, laryngitis or tracheitis. "
Ambrobene is indicated for the treatment of:
in acute, chronic and infectious respiratory diseases
- United with difficulty coughing
- Bronchitis
- Laryngitis
- Inflammation of the trachea
- Facilitates expectoration
- Thins mucus
- Protective effect on the respiratory mucosa
Dosage and method of use
Adolescents over 12 years and adults:1 capsule once daily, preferably in the morning. The capsules are taken whole, after a meal, with a sufficient amount of liquid. The usual duration of treatment with Ambrobene is 7-10 days.
Contraindications
Not intended for children under 12 years of age. The use of Ambrobene in pregnancy and during breastfeeding will be decided by your doctor. Read the package insert carefully.
Storage
Always keep the product out of the sight and reach of children. Keep in the original packaging to protect the product from light. Store at temperatures up to 25 °C. Do not use after the expiry date stated on the box and blister after EXP. The expiry date shall be the last day of the month indicated. Do not dispose of any medicines in wastewater or household waste. Ask your pharmacist how to dispose of products you no longer use. These measures help protect the environment.
Notice
Over-the-counter medicine. Read the full package leaflet carefully before taking this medicine. One capsule contains ambroxol hydrochloridum 75 mg. Excipients are microcrystalline cellulose, carmellose sodium, hydroxypropylmethylcellulose, dispersion of methacrylate copolymer RS 30 %, triethyl citrate, precipitated silica, gelatin, titanium dioxide, yellow iron oxide, red iron oxide, black iron oxide.
Manufacturer's address:
Teva Pharmaceuticals CR s. r. o., Sokolovská 136/A, 180 00 Prague
Specifications
Active ingredient
Category
Form
Usage
Packaging
Storage temperature
Identifiers
Pharmacotherapeutic group
Product characteristics
Teva Pharmaceuticals CR, s.r.o., Sokolovská 136/A, 180 00 Praha, CZ, +420548226521, [email protected] www.teva.cz
Specifications can be changed without notice. Images are for illustrative purposes only.
